Helios IV - Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system
Australia TGA ARTG Registered Device · Laseraid International Pty Ltd · Laseroptek Co Ltd · Class IIb · Started August 05, 2022
Good Name: Laseraid International Pty Ltd - Helios IV - Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- August 05, 2022
- Effective Date
- August 05, 2022
- Country
- South Korea
- Address
- #114 #116 #117 #203 #204 Hyundai I Valley 31, Galmachi-ro 244beon-gil Jungwon-gu, Seongnam-si Gyeonggi-do, Korea, 13212
Removal or lightening of unwanted hair, tattoo removal, treatment of vascular lesions, telangiectaias, spider angioma, cherry angioma, spider nevi, treatment of pigmented lesions.
Access comprehensive regulatory information for Helios IV - Dermatological Nd:YAG/frequency-doubled Nd:YAG laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Laseraid International Pty Ltd, manufactured by Laseroptek Co Ltd in South Korea. The device registration started on August 05, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.